KRRO SCHEDULE 13G/A: SEC filing
A Schedule 13G/A amendment was
Filed with the SEC on · accession 0001172661-26-003427
KRRO filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Aug 14, 2026. A Schedule 13G/A amendment was filed regarding beneficial ownership of Korro Bio, Inc. (KRRO) common stock. The stock moved -0.1% by the first close after the filing.
Summary of the filing
A Schedule 13G/A amendment was filed regarding beneficial ownership of Korro Bio, Inc. (KRRO) common stock. The filing indicates a change in a holder's passive ownership position.
Key details
How KRRO stock reacted
Close before
$13.29
Aug 13, 2026
First close after
-0.08%
$13.28
5 trading days
-2.48%
$12.96
Since filing
+10.99%
$14.75
✦ Ask GOAX AI about this filing — what it means for KRRO, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for KRRO?
Click hereFrequently asked questions
What did KRRO file with the SEC on Aug 14, 2026?
KRRO filed a SCHEDULE 13G/A (SEC filing). A Schedule 13G/A amendment was filed regarding beneficial ownership of Korro Bio, Inc. (KRRO) common stock. The filing indicates a change in a holder's passive ownership position.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did KRRO stock react to this filing?
KRRO closed at $13.29 before the filing and $13.28 on Aug 14, 2026 (-0.08%). Five trading days later: $12.96 (-2.48%).
Other KRRO SEC filings
- 10-Q · SEC filingNov 5, 2026
- 8-K · Contract lossNov 5, 2026
- SCHEDULE 13G/A · SEC filingOct 27, 2026
- 8-K · SEC filingOct 22, 2026
- 8-K · Fda approvalOct 5, 2026
- 8-K · Fda approvalAug 19, 2026
- 10-Q · SEC filingAug 6, 2026
- 8-K · Material agreementAug 6, 2026
- 8-K · Board changeJun 11, 2026
- 8-K · SEC filingMay 19, 2026
Get alerts when KRRO files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days